BACKGROUND: Low tidal volume (Vt) ventilation for ARDS is a well-accepted concept. However, controversy persists regarding the optimal ventilator settings for patients without ARDS receiving mechanical ventilation. This study tested the hypothesis that ventilator settings influence the development of new ARDS. METHODS: Retrospective analysis of patients from the Multi Parameter Intelligent Monitoring of Intensive Care-II project database who received mechanical ventilation for > or = 48 h between 2001 and 2005. RESULTS: A total of 2,583 patients required > 48 h of ventilation. Of 789 patients who did not have ARDS at hospital admission, ARDS developed in 152 patients (19%). Univariate analysis revealed high peak inspiratory pressure (odds ratio [OR], 1.53 per SD; 95% confidence interval [CI], 1.28 to 1.84), increasing positive end-expiratory pressure (OR, 1.35 per SD; 95% CI, 1.15 to 1.58), and Vt (OR, 1.36 per SD; 95% CI, 1.12 to 1.64) to be significant risk factors. Major nonventilator risk factors for ARDS included sepsis, low pH, elevated lactate, low albumin, transfusion of packed RBCs, transfusion of plasma, high net fluid balance, and low respiratory compliance. Multivariable logistic regression showed that peak pressure (OR, 1.31 per SD; 95% CI, 1.08 to 1.59), high net fluid balance (OR, 1.3 per SD; 95% CI, 1.09 to 1.56), transfusion of plasma (OR, 1.26 per SD; 95% CI, 1.07 to 1.49), sepsis (OR, 1.57; 95% CI, 1.00 to 2.45), and Vt (OR, 1.29 per SD; 95% CI, 1.02 to 1.52) were significantly associated with the development of ARDS. CONCLUSIONS: The associations between the development of ARDS and clinical interventions, including high airway pressures, high Vt, positive fluid balance, and transfusion of blood products, suggests that ARDS may be a preventable complication in some cases.
BACKGROUND: Low tidal volume (Vt) ventilation for ARDS is a well-accepted concept. However, controversy persists regarding the optimal ventilator settings for patients without ARDS receiving mechanical ventilation. This study tested the hypothesis that ventilator settings influence the development of new ARDS. METHODS: Retrospective analysis of patients from the Multi Parameter Intelligent Monitoring of Intensive Care-II project database who received mechanical ventilation for > or = 48 h between 2001 and 2005. RESULTS: A total of 2,583 patients required > 48 h of ventilation. Of 789 patients who did not have ARDS at hospital admission, ARDS developed in 152 patients (19%). Univariate analysis revealed high peak inspiratory pressure (odds ratio [OR], 1.53 per SD; 95% confidence interval [CI], 1.28 to 1.84), increasing positive end-expiratory pressure (OR, 1.35 per SD; 95% CI, 1.15 to 1.58), and Vt (OR, 1.36 per SD; 95% CI, 1.12 to 1.64) to be significant risk factors. Major nonventilator risk factors for ARDS included sepsis, low pH, elevated lactate, low albumin, transfusion of packed RBCs, transfusion of plasma, high net fluid balance, and low respiratory compliance. Multivariable logistic regression showed that peak pressure (OR, 1.31 per SD; 95% CI, 1.08 to 1.59), high net fluid balance (OR, 1.3 per SD; 95% CI, 1.09 to 1.56), transfusion of plasma (OR, 1.26 per SD; 95% CI, 1.07 to 1.49), sepsis (OR, 1.57; 95% CI, 1.00 to 2.45), and Vt (OR, 1.29 per SD; 95% CI, 1.02 to 1.52) were significantly associated with the development of ARDS. CONCLUSIONS: The associations between the development of ARDS and clinical interventions, including high airway pressures, high Vt, positive fluid balance, and transfusion of blood products, suggests that ARDS may be a preventable complication in some cases.
Authors: Andrés Esteban; Antonio Anzueto; Fernando Frutos; Inmaculada Alía; Laurent Brochard; Thomas E Stewart; Salvador Benito; Scott K Epstein; Carlos Apezteguía; Peter Nightingale; Alejandro C Arroliga; Martin J Tobin Journal: JAMA Date: 2002-01-16 Impact factor: 56.272
Authors: Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler Journal: N Engl J Med Date: 2000-05-04 Impact factor: 91.245
Authors: L W Eberhard; D J Morabito; M A Matthay; R C Mackersie; A R Campbell; J D Marks; J A Alonso; J F Pittet Journal: Crit Care Med Date: 2000-01 Impact factor: 7.598
Authors: Murat Yilmaz; Mark T Keegan; Remzi Iscimen; Bekele Afessa; Curtis F Buck; Rolf D Hubmayr; Ognjen Gajic Journal: Crit Care Med Date: 2007-07 Impact factor: 7.598
Authors: Carol Spada; Rikesh Gandhi; Sanjay R Patel; Paul Nuccio; Gerald L Weinhouse; Po-Shun Lee Journal: J Crit Care Date: 2010-10-30 Impact factor: 3.425
Authors: Mohammed Saeed; Mauricio Villarroel; Andrew T Reisner; Gari Clifford; Li-Wei Lehman; George Moody; Thomas Heldt; Tin H Kyaw; Benjamin Moody; Roger G Mark Journal: Crit Care Med Date: 2011-05 Impact factor: 7.598
Authors: Andrew M Naidech; Bernard R Bendok; Paul Tamul; Sarice L Bassin; Charles M Watts; H Hunt Batjer; Thomas P Bleck Journal: Neurocrit Care Date: 2008-09-27 Impact factor: 3.210
Authors: Steven Y Chang; Ousama Dabbagh; Ognen Gajic; Amee Patrawalla; Marie-Carmelle Elie; Daniel S Talmor; Atul Malhotra; Adebola Adesanya; Harry L Anderson; James M Blum; Pauline K Park; Michelle Ng Gong Journal: Respir Care Date: 2013-04 Impact factor: 2.258
Authors: Pedro L Silva; Fernanda F Cruz; Livia C Fujisaki; Gisele P Oliveira; Cynthia S Samary; Debora S Ornellas; Tatiana Maron-Gutierrez; Nazareth N Rocha; Regina Goldenberg; Cristiane S N B Garcia; Marcelo M Morales; Vera L Capelozzi; Marcelo Gama de Abreu; Paolo Pelosi; Patricia R M Rocco Journal: Crit Care Date: 2010-06-14 Impact factor: 9.097
Authors: Natalie Urwyler; Sven Trelle; Lorenz Theiler; Peter Jüni; Lukas P Staub; Cedric Luyet; Lorenzo Alberio; Kay Stricker; Robert Greif Journal: Trials Date: 2009-11-23 Impact factor: 2.279